SARS-CoV-2 vaccine (ID Pharma/Shanghai Public Health Clinical Center Fudan University)

N/A

Report date: 2025/01/26 17:04:28

Base Information

Drug NameSARS-CoV-2 vaccine (ID Pharma/Shanghai Public Health Clinical Center Fudan University)
Drug Alias Namerecombinant viral vector vaccine (ID Pharma/Shanghai Public Health Clinical Center Fudan University)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesID Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesID Pharma Co LtdFudan University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A